- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02636530
Effect of Two Exercise Programs on Bone Strength and Architecture
January 6, 2022 updated by: University of Colorado, Denver
Bone responds according to the load placed on it.
In this study, investigators want to know if exercise that loads the body in exercises, like walking or jogging (Ground Reaction Forces: GRF), affects bone differently than exercises that load the joints, like weight lifting (Joint Reaction Forces: JRF).
Participants will exercise at least 3 times a week for 6 months.
Measures of bone strength and mass, muscular strength, and aerobic fitness will be taken at the beginning and the end of the 6 month program.
Period blood samples will be taken for future analysis of blood markers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Anschutz Medical Campus
-
Denver, Colorado, United States
- Veteran's Affairs Eastern Colorado Healthcare System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- non-smoker
- in generally good health
- not physically active (less than 60 minutes of purposeful exercise/week)
- able to travel to the exercise facility a minimum of 3 times/week
Exclusion Criteria:
- use of glucocorticoids
- abnormal resting EKG
- angina and/or evidence of acute myocardial ischemia during a treadmill test
- resting blood pressure above 150 mmHg systolic of 90 mmHg diastolic
- anti-resorptive drug use in the last 2 years
- initiation of treatments that could impact bone metabolism (diuretics, hormones, bine anabolic agents) in the prior 6 months
- dual-energy x-ray absorptiometry (DXA) t-score <+ -2.5 at the femoral neck and/or lumbar spine
- serum vitamin D concentration <20 ng/mL
- uncontrolled thyroid disease
- any contraindications to regular exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ground Reaction Forces
Participants will have an individualized exercise program that includes walking, jogging, stair climbing, and box jumping.
|
6 month exercise program that loads the body via gravitational forces.
|
|
Experimental: Joint Reaction Forces
Participants will have an individualized exercise program that includes weight lifting and aerobic rowing.
|
6 month exercise program that loads the body via loading the joints.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Volumetric Bone Mineral Density (vBMD)
Time Frame: Baseline and 6 month
|
Measured via quantitative computed tomography (QCT)
|
Baseline and 6 month
|
|
Change in Areal Bone Mineral Density (aBMD)
Time Frame: Baseline and 6 month
|
Measured via dual-energy x-ray absorptiometry (DXA)
|
Baseline and 6 month
|
|
Change in Bone Strength
Time Frame: Baseline and 6 month
|
Measured via finite element analysis (FEA) from QCT
|
Baseline and 6 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in 1-Repetition Maximum (1RM)
Time Frame: Baseline and 6 month
|
Baseline and 6 month
|
|
Change in Maximal Oxygen Uptake (cardiovascular fitness)
Time Frame: Baseline and 6 month
|
Baseline and 6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
December 1, 2021
Study Completion (Actual)
December 1, 2021
Study Registration Dates
First Submitted
December 17, 2015
First Submitted That Met QC Criteria
December 18, 2015
First Posted (Estimate)
December 21, 2015
Study Record Updates
Last Update Posted (Actual)
January 11, 2022
Last Update Submitted That Met QC Criteria
January 6, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-1451
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
National Taiwan University HospitalNational Taiwan UniversityNot yet recruitingOsteoporosis | Postmenopausal Osteoporosis | Postmenopausal Osteopenia | Primary OsteoporosisTaiwan
-
National Taiwan University HospitalRecruitingOsteoporosis | Osteoporosis PostmenopausalTaiwan
-
AmgenCompletedPostmenopausal Osteoporosis (PMO)Japan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisPakistan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisBelgium, Luxembourg, Austria, Greece, Ireland
-
Hoffmann-La RocheNo longer availablePostmenopausal OsteoporosisTaiwan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisPoland, Slovakia, Hungary, Russian Federation, Latvia, Romania, Slovenia
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
Clinical Trials on Ground Reaction Forces
-
Texas A&M UniversityCompletedCholesterol, LDL | Cholesterol, HDL | Research SubjectsUnited States
-
Campus Bio-Medico UniversityCompletedLaryngoscopy | Tracheal IntubationItaly
-
University of California, DavisRockefeller UniversityCompleted
-
Pôle Saint HélierCompletedStroke | Multiple Sclerosis | Spinal Cord InjuriesFrance
-
University of AlbertaCompleted
-
Oxford University Hospitals NHS TrustCompletedCerebral Infarction | Intracranial Hemorrhages | Acute Ischemic Stroke | Cerebral Edema | Hydrocephalus | Cerebral InjuryUnited Kingdom
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting
-
Boston UniversityThe University of Texas Health Science Center at San Antonio; RANDUnknownDeploymentUnited States
-
Aga Khan UniversityNot yet recruitingHypothermia; Anesthesia | Nausea and Vomiting, Postoperative
-
Texas A&M UniversityCompletedLipoprotein Metabolism Disorder